Sun Pharmaceutical Industries posts consolidated Q2 FY26 PAT higher at Rs. 3,137.09 Cr

Sun Pharmaceutical Industries posts consolidated Q2 FY26 PAT higher at Rs. 3,137.09 Cr

By: IPP Bureau

Last updated : November 08, 2025 2:41 pm



Sun Pharmaceutical Industries has reported total income of Rs. 14,948.23 crore during the period ended September 30, 2025


Sun Pharmaceutical Industries Limited has reported consolidated financial results for the period ended September 30, 2025.

Sun Pharmaceutical Industries has posted net profit of Rs. 3,124.95 crore for the period ended September 30, 2025 as against net profit of Rs. 2,278.63 crores for the period ended June 30, 2025. The company posted net profit of Rs. 3,040.16 crore for the period ended September 30, 2024.

Sun Pharmaceutical Industries has reported total income of Rs. 14,948.23 crore during the period ended September 30, 2025 as compared to Rs. 14,315.86 crore during the period ended June 30, 2025. The company has reported total income of Rs. 13,645.39 crore during the period ended September 30, 2024.

For the Half Year ended September 30, 2025, Sun Pharmaceutical Industries has reported total income of Rs. 29,264.09 crore as compared to Rs. 26,830.69 crore during the 6 months period ended September 30, 2024.

The company has posted net profit of Rs. 5,396.58 crore for the 6 months period ended September 30, 2025 as against net profit of Rs. 5,875.78 crores for the 6 Months period ended September 30, 2024.

Sun Pharmaceutical Industries Limited

First Published : November 08, 2025 12:00 am